Penta Faculty

PENTA Faculty


George Abongomera (MD, MSc, PhD) is a physician and researcher with several years of experience conducting clinical trials and implementating research in sub-Saharan Africa. He is currently working as a post-doctoral researcher in Global Health at the Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Switzerland.

Prior to moving to Switzerland, George was based at the Joint Clinical Research Centre in Kampala, Uganda, where he was involved in infectious diseases treatment and clinical trials, dealing with HIV/AIDS and TB in particular. He also coordinated and implemented a research project focusing on cost-effective and safe delivery of Antiretroviral Therapy to lower level rural health facilities in Uganda, Malawi and Zimbabwe. This research contributed significantly to his PhD work in Medical Sciences at the faculty of Medicine, University of Antwerp, Belgium.

bamford_photoDr Alasdair Bamford is a consultant in paediatric infectious diseases at Great Ormond Street Hospital, London, UK and an Honorary Senior Lecturer at the Institute of Child Health, London, UK. He also works as a clinical advisor to paediatric clinical trials and cohort studies at the MRC clinical trials unit, London, UK. He has over 10 years of experience in working with children, adolescents and families affected by HIV. He is one of the lead authors for the Penta European guidelines for treatment of HIV infected children and chairs the Penta guideline writing group. His research interests include B and T cell immunity in HIV infected children and vaccine related immunity. He is on the Executive Committee of the UK Children’s HIV Association and a member of the Penta steering committee and UK National Study of HIV in Pregnancy and Childhood steering committee. He is a regular faculty member for both online and residential Penta courses on paediatric HIV in Europe and Russia.

david-burguerDavid Burger (Oct. 20, 1964) received his Pharmacy Degree at the Utrecht University in 1990. He completed his PhD thesis, entitled “Bio-analysis and clinical pharmacokinetics of antiretroviral agents in HIV-infected individuals” at the Slotervaart Hospital, Amsterdam, in 1994. After this, he moved to the Radboud University Medical Centre, Nijmegen, for his hospital pharmacist training. From 1997 to 2005, he has been working as a hospital pharmacist responsible for the coordination of clinical trials conducted at the Radboud University Medical Centre. Since 1997 he has been leading a research group focussing on clinical pharmacology of antimicrobial agents with emphasis on HIV, TB, fungal infections, and HCV. He is member of the Editorial Board of the and websites on behalf of the European AIDS Clinical Society. He is a member of the Organizing Committee of the annual International Workshop on Clinical Pharmacology of HIV/Hepatitis Therapy and is on the panel for HIV treatment guidelines of the IAS-USA. Since April 2011 he has been appointed as a Professor of Clinical Pharmacy at the Radboud University Nijmegen. He is (co-) author of more than 300 publications in this field. His topics of interest are drug-drug interactions, paediatric pharmacology, therapeutic drug monitoring, and operational research in resource-limited countries.

mutsa-bwakuraMutsa Bwakura is a Consultant Pediatrician and Senior Lecturer within the department of Pediatrics and Child Health at the University of Zimbabwe College of Health Sciences. She has served as the project leader for the ARROW and REALITY clinical trials and is also affiliated to the IMPAACT network where she has been site Principal Investigator for a number of clinical trials in children including ART strategies for children who were exposed to nevirapine for PMTCT and those who were not.  Mutsa is currently a Wellcome Trust Training Fellow where her research is focusing on the long term outcomes of severely malnourished HIV and HIV uninfected children following discharge from hospital.

guidocastelliCurrent Position: Chief of Vaccination unit – University-Hospital department, University of Tor Vergata and Pediatric hospital Bambino Gesù – Rome; Lecturer of infectious diseases at the Nursing School of Tor Vergata University – Rome; Director of the Postgraduate school of Pediatrics – Bugando University College of Health Science Mwanza Tanzania.  Positions Held: Chief of Pediatrics in OPBG of Palidoro; Researcher at Department of Paediatrics Univ. La Sapienza, Rome; Paediatric General Practitioner for Italian National Health System; Visiting scientist at the Immunology and Infectious Diseases Department at Paediatric Clinic in Miami, USA; Full time medical house officer and Responsible of AIDS Unit – Ospedale Pediatrico Bambino Gesù – Rome; Teacher of infectious diseases at the School of Specialization in Paediatrics of Tor Vergata University – Rome.  Member of the Steering Committee of the Paediatric European Network for Treatment of AIDS (PENTA); Member of the Steering Committee of the Italian Register for HIV infection in children; Member of the Board of Directors of the Italian Society of Paediatric Infectious Diseases.

Author and co-author of more than 180 papers in National and International Scientific Journals.

chishalachabalaDr Chishala Chabala is Paediatrician and Honorary Lecturer in the Department of Paediatrics and Child Health, at the University Teaching Hospital/University of Zambia, Lusaka, Zambia. He is currently the site principal investigator for the SHINE trial; a randomized controlled trial clinical trial of shorter treatment for children with minimal TB. Previously he was the site project leader for the CHAPAS 3 Trial that evaluated the pharmacokinetics, acceptability and adherence to fixed dose combination antiretroviral therapies for HIV-infected children in Zambia and Uganda conducted in 2010-2014. He has participated as a faculty member in Tr@inforPedHIV courses in Zambia (2011 and 2015) and Uganda (2012). He has vast clinical expertise in the management of HIV infection and tuberculosis in children.

magdaconwayMagda has worked with children, young people and families living with HIV for the last 14 years. For 5 years she was the UK policy lead and for the last 8 years she has worked as a freelancer for a number of organisations including the Children’s HIV Association, Medical Research Council, Penta and UNICEF for the CIS/CEE region, specialising in the psychosocial support needs of children, adolescents and families living with HIV.

In this capacity she managed a portfolio of work from direct work with children and families through to writing guidance and developing and delivering training programmes. She has been part of the Penta faculty for some years, leading on youth and community engagement in international paediatric HIV training courses.

Since 2013 Magda has carried out work for UNICEF in the CIS/CEE region, developing training and resources to develop support provision for adolescents living with HIV. Prior to this, Magda worked with looked after children, ran community development projects and worked in HIV/sexual health promotion and teenage pregnancy reduction.

She has co-authored a number of publications, some of which include:

“HIV in Schools: A guide to the pastoral care needs of children living with HIV.” Conway, M (NCB, 2005, updated 2015)

“Talking to children about their health diagnosis.” Donaghy, S. Melvin, D. Conway, M (CHIVA, 2010)

“Don’t forget the children. Guidance for the HIV testing of children of HIV positive parents.” Wood, C. Conway, M (Mediscript, 2009)

“Developing Support Services for Children, Young People and Families living with HIV.” Conway, M (NCB, 2006).

markcottonDr Cotton is Head of Division of Paediatric Infectious Diseases and Director of the Family Infectious Diseases Clinical Research Unit at Tygerberg Children’s Hospital (TCH), Stellenbosch University (SU). He undertook a fellowship in paediatric infectious diseases at University of Colorado between 1991 and 1995. He is affiliated to the IMPAACT and PENTA networks and has provided technical support for WHO initiatives since 2004 on the HIV Classification for HIV, antiretroviral guidelines and TB-HIV co-infection. He was co-PI and investigator in several clinical trials in children, both on ART strategy (CHER) and isoniazid prophylaxis and also ARV pharmacokinetics in HIV-infected children. He is the principal investigator for the SU Clinical Trial Unit (SUN-CTU) with special focus on tuberculosis and HIV. He is involved in vaccine studies for TB and RSV and is including a recombinant BCG vaccine. He is interested in clinical infectious diseases, and all aspects of HIV in children and adolescents. , young people and families living with HIV for the last 14 years.

rashidaferrandDr Rashida Ferrand is a Wellcome Trust Clinical Fellow and a Reader at the London School of Hygiene and Tropical Medicine. Her research is focused on HIV infection in older children and adolescents.

From 2003 onwards, Dr Ferrand has been based in Zimbabwe and London, studying the clinical epidemiology of HIV infection in adolescents. Her work highlighted an emerging epidemic of adolescent long-term survivors of vertical HIV transmission in Southern Africa, a substantial proportion undiagnosed, with complex clinical and psychosocial issues.

Dr Ferrand’s current work focuses on investigating approaches to increase access to HIV diagnosis and care and investigation of chronic HIV-related complications, in adolescents.  With colleagues in London and Malawi, she is studying chronic lung disease among vertically-infected adolescents and investigating potential intervention strategies.  She also collaborates with the University of Oxford on studies to investigate the immunological correlates of slow progression of HIV infection in long-term survivors of vertical HIV transmission.

carolinefosterDr Caroline Foster is a Consultant in Adolescent HIV and Infectious Diseases at Imperial College Healthcare NHS Trust and is the clinical lead for transitional care in HIV. Current research studies include, the long term outcomes for adults born with HIV, co-receptor tropism evolution within perinatal infection, the characterisation of the latent reservoir and the development of in vitro therapeutic vaccines in paediatric HIV. Research/education/guideline development and lecturing includes BHIVA, CHIVA, HYPNET, CHIPS, AALPHI, PENTA, UNICEF and the WHO.

annamariagerettiAnna Maria Geretti, MD, PhD, FRCPath, is Professor of Virology & Infectious Diseases and Honorary Consultant in Infectious Diseases. Having trained in Italy, the Netherlands and the United Kingdom, she is now based at the Institute of Infection & Global Health, University of Liverpool, where she consults on viral infections with focus on HIV and viral hepatitis, teaches and conducts research. Her research targets antiviral therapy, virus genetic diversity and diagnostics, and has led to over 200 publications. She is Secretary of the European AIDS Clinical Society. She contributes to policy formulation, education, and communication both nationally and internationally, and enthusiastically shares her expertise to train healthcare professionals and scientists.


Director of the Paediatric Infectious Diseases Unit at the Department of Woman’s and Child’s Health of the University of Padova.
Director of the Paediatric Infectious Diseases Unit at the Department of Woman’s and Child’s Health of the University of Padova. Member of the Italian National Committee for the fighta gainst AIDS and other infectious diseases, Ministry of Health (1998-2000).

WHO Consultant and advisor on several projects on paediatric HIV and paediatric care in developing countries (1989 ongoing).

Head of the Paediatric European Network Treatment of AIDS PENTA (since1993) and President of the PENTA Foundation (2004 ongoing).

Promoter and coordinator (2004 ongoing) of “Tr@inforPedHIV”, a training program including distance and residential learning for developing countries (different funding sources including EU, Regional Gvts, UNICEF, private organisations, ESPID etc).
Honorary Senior Lecturer in the Centre for Paediatric Epidemiology and Biostatistics of the Institute of Child Health in London (2002-2010).
Chair of the Education Committee of the European Society Paediatric Infectious Disease (ESPID) (2006-2010).
Member of the Scientific Committee and of the Faculty of the “Diploma in Paediatric Infectious Disease” – University of Oxford, UK (2008 ongoing).
Consultant at the Ospedale Pediatrico Bambino Gesu’, City of Vatican, Rome (2010 ongoing).
Chief of the Paediatric Clinical Research and Trials Unit of the Azienda Ospedaliera/University of Padova (2011-2014).


Professor Gibb is Senior Clinical Scientist and MRC Programme Leader at the MRC Clinical Trials Unit, London and Professor of Epidemiology at University College London (UCL) as well as Honorary Consultant Paediatrician at Great Ormond Street Hospital.

Over the last 20 years she set up and coordinated a network of clinical trials and cohorts, across Europe, Thailand and South America mainly addressing questions in paediatric HIV infection. Since 1999 her focus has expanded to Africa where she runs large trials, addressing strategy questions in adult and paediatric HIV infection and more recently in malaria and tuberculosis, collaborating widely with clinical and research centres in 6 countries in East and Southern Africa.  Wide inter-disciplinary collaboration with health economists, pharmacologists, social and basic scientists and innovators of medicines for children are incorporated into trial programmes. Capacity development is an important feature of the overseas collaborations, including interactive courses in paediatric HIV, on-the-ground training in clinical trials and PhD mentorship. She serves on a number of WHO advisory and guideline committees and continues a clinical commitment at the HIV Family clinic at the Great Ormond Street Hospital for Children in London, which she started in 1991.

She is a highly experienced researcher in the field of paediatric HIV, and has over 200 publications in the field. She has initiated and led on organising Tr@inforPedHIV in African centres.

maryhepburnDr Mary Hepburn trained first as a general practitioner then as an obstetrician and gynaecologist. She established and for 30 years until her retirement from clinical practice in 2014 was consultant in charge of the Glasgow Women’s Reproductive Health Service, (WRHS) a city wide service for women with social problems. WRHS was the regional service providing reproductive healthcare for women infected with or affected by blood borne viruses including HIV and HCV. Consequently for 30 years all pregnant HIV+ve women in West of Scotland (and many from other regions as well) were under her care. She supported colleagues in other centres nationally and internationally in the development of specialised services for women with social problems and contributed to professional and government strategic development and development of undergraduate and postgraduate training. In 2015 she was awarded OBE for her work. She continues non clinical work including training and support for service development nationally and internationally.

nigelkleinNigel Klein a Professor and Consultant in Paediatric Infectious Diseases and Immunology at Great Ormond Street Children’s Hospital, London, and the Institute of Child Health, University College London. He trained at the University College London (UCL), obtaining degrees in Anatomy and in Medicine. He established and led the Infectious Diseases and Microbiology Unit at ICH until 2014 and established and led the Department of Infection at UCL for 5 years until 2008. He has been working in the fields of Infectious Diseases for many years and has a particular interest in Meningitis, Sepsis, Innate Immunity, premature labour and HIV. He has been a member of several boards including the Wellcome Trust Infection and Immunity Board,  Chair of the Grants Panel for Meningitis UK,  a member of the Meningitis Research Foundation Grants Panel and is now Chair of the Action Medical Research Panel. He served on the Malawi Welcome Trust International Scientific Advisory Board and the MRC International Nutrition Group Scientific Advisory Board. He is a member of the PENTA Immunology and Virology committee, and was a member of the Steering Group for the Technology Strategy Board’s Innovation Platform on the Detection and Identification of Infectious Agents (DIIA). He has  published more than 300 papers, many in high impact journals. He  has  supervised more than 30 PhD students of which 16 have or are Clinical Fellows. He is currently on the Paediatric Medicines Expert Advisory Group of the Medicines and Healthcare Products Regulatory Agency.  He has recently been appointed Lead for Maternal, Child and Adolescent Health at the newly created Wellcome Trust Unified Institute based in KwazuluNatal in South Africa.

nataliakotovaNatalia Vladimirovna Kotova – MD, Professor, Department of Pediatrics №1 of Odessa National Medical University, Ukraine. NATALIA has carried out medical and advisory work in the Odesa Oblast Children’s Hospital for 35 years. She is a member of the Association of pediatricians and neonatologists of Ukraine. Lecturer in HIV infection FOR PENTA COURSES SINCE 2013. Priority areas include HIV infection, neonatology, pediatrics.


I am a consultant in paediatric infectious diseases and chief of service for Children at Imperial College Healthcare NHS Trust, London. Prevention of transmission of HIV from mother to infant, and management of HIV infected children and young people are my main areas of clinical work. I am also interested in other congenital infections (syphilis, toxoplasmosis, CMV etc) and their prevention. I am a member of the steering committee of PENTA (Paediatric European Network for the Treatment of AIDS) and participate in treatment trials for HIV infected children.

For the last 3 years I have had the privilege to be chair the European Society for Paediatric Infectious Diseases (ESPID) training committee, this has been a great opportunity to work within the ESPID family to develop local and distance learning courses for ESPID members, as well as the paediatric community more widely. In 2005, I initiated Tr@inforPedHIV, a unique online and residential course for paediatric HIV. This course has trained more than a 1000 healthcare workers around the world on the management of paediatric HIV. Within ESPID we now have 2 further online courses and many more regional residential courses – a testament to the high regard in which our society holds education and dissemination of knowledge of paediatric infectious diseases.

victormusiimeVictor is a Senior Lecturer at Makerere University, College of Health Sciences, Department of Paediatrics and Child Health, in Kampala, Uganda; and an Investigator at Joint Clinical Research Centre (JCRC), Kampala, Uganda. He has worked as a Paediatrician at JCRC in HIV research, clinical care and treatment since 2004.  He was part and led a team of personnel that initiated and followed up a cohort of over 2000 HIV-infected children on antiretroviral therapy, provided treatment for opportunistic infections, as well as other forms of comprehensive Paediatric HIV care and treatment.  He has also been an investigator on several research protocols, including the ARROW clinical trial, the CHAPAS 3 clinical trial, the PENTA 16 clinical trial, and the REALITY trial. He is one of the 2 programme coordinators for the Master of Medicine (MMED) course in the department of paediatrics and child health at Makerere University. His clinical and research interests are in Paediatric HIV-infection, antiretroviral therapy, child nutrition and infectious diseases.

timniehuesDirector, Centre for Child Health and Adolescence, HELIOS Klinikum Krefeld, Germany;  Academic Hospital, RWTH Aachen;
1991 onwards Postdoctoral Fellow, Department of Molecular Medicine, North Shore University Hospital (NSUH), Cornell University New York;
1993 onwards Intern, Resident, Fellow, Registrar, Lecturer at University Children s Hospital Heinrich Heine University Düsseldorf;
1998 onwards Leading author of German National Guidelines on the Treatment of HIV infected Children
2006 onwards Member of Steering Committee of Paediatric European Network for the Treatment of AIDS (PENTA)
2007 onwards Director, Centre for Child Health and Adolescence, HELIOS Klinikum Krefeld, Germany;
2007 onwards Member of the German National Committee for Multiple Choice Questions in Medicine
2008 onwards Professor of Pediatrics (Heinrich Heine University Düsseldorf),
2009 onwards; Co-author of PENTA Guidelines for Treatment of children with HIV infection;
2010 onwards Speaker, Study Group Pediatric Immunology (AKPI) of the German Society of Immunology (DGfI)
2011 onwards Expert at the European Medicines Agency EMA, Special advisory group HIV, Virology
2015 onwards Member Immunodeficiency Group. German National Committee on Vaccination/Ständige Impfkommission (STIKO) at Robert-Koch-Institut (RKI)


Antoni NOGUERA-JULIAN, MD, Phd, is a Consultant in Pediatric Infectious Diseases at Hospital Sant Joan de Déu in Barcelona (Spain). He is a Lecturer of Pediatrics at Universitat de Barcelona and coordinates the Master Course in Pediatric Health (Hospital de Nens, Universitat de Barcelona) as well. He graduated from the Universitat de Barcelona in 1997 and completed his internship and residency in Pediatrics at Hospital Sant Joan de Déu in 2003. Dr. Noguera-Julian´s areas of interest include: HIV and other vertically-transmitted infections and tuberculosis in the pediatric age

Dr. Noguera-Julian is part of the PENTA SC since 2010 and has given lectures in several PENTA training courses on HIV infection in children and adolescents in Latin America.

andyprendergastDPhil, University of Oxford (Paediatric HIV infection) 2005-2009; Academic Clinical Lecturer in Paediatric Infection and Immunity, University of Oxford, 2009-2011; Honorary Clinician Scientist, MRC Clinical Trials Unit, from 2009; Associate Faculty, Department of International Health, Johns Hopkins Bloomberg School of Public Health, from 2010; Senior Lecturer in Paediatric Infection and Immunity, Queen Mary University of London, from 2011; Honorary Consultant in Paediatric Infection and Immunity, Barts and the London Children’s Hospital, from 2011; Wellcome Trust Intermediate Clinical Fellow, based in Zimbabwe undertaking clinical HIV work and research, from 2011; Honorary Lecturer, Department of Paediatrics and Child Health, University of Zimbabwe, from 2012; Member of Guideline Committee, Children’s HIV Association of UK and Ireland, 2009-2011; 23 peer-reviewed publications on paediatric HIV, 2007-2011; Member of WHO Technical Reference Group on Paediatric ART/HIV Care, 2008-present; Member of Trial Management Group, ARROW Trial (HIV trial conducted in Uganda/ZImbabwe), 2009-present; Member of Endpoint Review Committee, ARROW Trial, 2009-present; Course Development Officer, Diploma in Paediatric Infectious Diseases, University of Oxford, 2010-present.

lubaokhonskaiaLiubov Okhonskaia, PhD, works as an Infectious Diseases consultant  in the Republican Clinical Infectious Diseases Hospital of the Ministry of Health of Russia, Saint Petersburg, since 2011. Liubov has been teaching on PENTA courses in Eastern Eutope and Central Asia since 2014 and has been one of the leading tutors on the online Russian course. Her current interests are HIV infection, HIV/TB coinfection and viral hepatitis in children and adults.

pablorojoPablo Rojo is a Pediatric Infectious Diseases Specialist of Hospital 12 de Octubre, Madrid, Spain. He is also Associate Professor of Complutense University, Madrid, Spain. He obtained his MD and PhD from Complutense University.

He has been a member of the Board of the Spanish Society of Pediatric Infectious Diseases (SEIP) from 2010 to 2014 and member of the ESPID Research Masterclass Committee since 2013. He is author and coauthor of over 80 peer reviewed scientific articles and book chapters. His main research activities are related to HIV, S. aureus and congenital CMV infection. Related to Pediatric HIV, he is member of the PENTA Steering Committee and EPPICC Committee; he has participated in many clinical trials with antiretrovirals and is part of the EPIICAL project pursuing a therapeutic vaccine for HIV-infected children. He participates as a Technical advisor for Pediatric HIV for Spanish Government, he participates in a collaborating project on Pediatric HIV in Equatorial Guinea and has also advised WHO in Pediatric HIV treatment.  Related to S. aureus he is focused on community-acquired S. aureus infection and virulence factors, he is the principal investigator of the European Project on Pediatric Invasive S. aureus Infections. Related to congenital CMV infection he is member of the Panel Group on congenital CMV of the Spanish Society of Pediatric Infectious Diseases and co-coordinator of the Spanish Cohort of congenital CMV. He co-organizes an International meeting on congenital CMV infection every two years in Madrid, Spain.

clairethorneReader in Infectious Disease Epidemiology, Population, Policy and Practice Programme, UCL Institute of Child Health, University College London, UK. Member, Executive Committee and Steering Committee of the Paediatric European Network for Treatment of AIDS (from 2006); Member Steering Committee of Collaboration of Observational HIV Epidemiological Research Europe (2005-2015); Member, Scientific Advisory Group, INSPIRE (INtegrating and Scaling up Pmtct through Implementation REsearch) research, World Health Organization, Geneva; Member, Scientific Committee, International Workshop on HIV Pediatrics (2009-2016); Academic Editor of PLoS One; consultancies for UK Department of Health, UNAIDS and UNICEF; teach on the immunisation and infectious diseases module of the MSc in Paediatric and Child Health, UCL; peer review for journals and for grant-giving bodies including Medical Research Council and Wellcome Trust; PhD supervision (7 completed, 3 ongoing).

joseramosMedicine degree: Universidad Complutense of Madrid, from 1977 until 1983. Specialization in Paediatrics. Hospital 12 de Octubre Madrid (1984-1988). Sub-speciality Infectious Diseases. Consultant in Paediatric Infectious diseases at the Section of Immunodeficiencies, Department of Paediatrics in Hospital 12 Octubre, Madrid until June 2006. Granted by the National Health System (FIS) at the Infectious Disease unit in St Jude Children´s Research Hospital, Memphis, Tennessee. June-October 1994. Head of Pediatrics University Hospital Getafe since July 2006. Degree in Medicine as Medical Doctor. Doctoral – thesis: Presented on October, 1993 at the Faculty of Medicine of the Complutense University of Madrid. Director of 7 doctoral thesis at the: University Complutense: Infectious Diseases-HIV. Associate Professor in Pediatrics at the Department of Paediatrics of the Complutense University of Madrid, since October 1998 to 2006. Accreditation by the National Agency of Quality and Accreditation (ANECA) for University Teaching Activities in 2011. Principal Investigator of 21 investigational projects, most on HIV-infection in children. Principal investigator of the Madrid cohort of HIV-infected children and the Madrid cohort of HIV infected mother-infant pairs. Author and co-author of 78 book chapters, and 214 publications until July 2011. Reviewer of several international and Spanish journals on Paediatrics and Infectious Diseases. Member of the PENTA Steering Committee (Paediatric European Network for the Treatment of AIDS) since March 1998. Member of the Spanish Advisory Committee of Plan Nacional del SIDA (Ministry of Health) since November 2000.


Dr Gareth Tudor-Williams is a Reader (Associate Professor) in Paediatric Infectious Diseases at Imperial College London, and Consultant Paediatrician at Imperial College Healthcare NHS Trust (ICHT), St. Mary’s Hospital, London.

Relevant experience: 2 yrs as Medical Officer, Save the Children Fund (UK) in Baglung, Nepal. 2 yrs Paed ID Fellowship at Duke University, N. Carolina. 3 yrs as Visiting Scientist/ Attending Paediatrician at National Institutes of Health, Bethesda, MD. Involved in Phase I, II, and III clinical trials for HIV infected children since 1989. Member, Scientific Steering Committee for Pediatric European Network for Treatment of AIDS (PENTA) since 1994. Founding chairman of the Children’s HIV Association of the UK and Ireland (CHIVA) in 2002.  Co-CI for PACTG390/PENPACT1 trial of treatment and switching strategies in HIV infected children, a trans-Atlantic collaboration [Lancet Infect Dis. 2011 Apr;11(4):273-283]. Co-founder, CHIVA-Africa programme. Clinical lead for trial of early therapy for infants in Durban, S. Africa (PEHSS study). Chair, Clinical Endpoint Review Committee for ARROW (1,200 HIV-infected children enrolled in Uganda and Zimbabwe). UK CI for trials of tenofovir paediatric formulation (Gilead), etravirine (TMC125 – Tibotec), and elvitegravir (Gilead) in HIV infected children. Chair, Data Monitoring Committee for PRINCE 1 and 2 atazanavir trials (BMS), and fosamprenavir trials (GSK). Member, DSMB for 13-valent pneumococcal vaccine studies in HIV infected children, then Chair DMC for multidose vaccine trial (Pfizer). Paediatric Expert, London Central Research Ethics Committee. Training Programme Director for academic trainees, London School of Paediatrics. Chair, Clinical Ethics Committee, ICHT.


Anna Turkova is a research clinician at the MRC CTU at UCL, London, and the Paediatric European Network for Treatment of AIDS (PENTA) and an Honorary Consultant Paediatrician at the Imperial College London Healthcare Trust and Great Ormond Street Hospital. She is a member of PENTA Faculty since 2011, and has been teaching on PENTA training courses in Eastern and Western Europe, Central Asia and Africa. She is jointly leading on-line PENTA training and residential courses in Eastern Europe and Central Asia. Anna is one of the lead authors for updating PENTA guidelines for treatment of paediatric HIV 2015-2016.

Prior coming to the UK in 2002, she worked for four years in Paediatric Infectious Diseases in Russia. In 2015 she was elected to the Executive Committee of the Children’s HIV Association (CHIVA), UK. She is a current chair of the CHIVA Guidelines Subcommittee. Anna is a member of the European Society for Paediatric Infectious Diseases (ESPID) and the Paediatric Tuberculosis Network European Trials group (pTBNet). Her special interests are HIV, co-infections, viral hepatitis and TB.


Alla Volokha – Doctor of Medicine, Professor of Pediatric Infectious Diseases and Pediatric Immunology in Shupyk National Medical Academy of Postgraduate Education, Kiev. Since 1992 she has been working in the field of infectious diseases in children and congenital immunodeficiencies, since 2000 – in the field of HIV. Author of 135 scientific papers, including 2 textbooks. Trained in leading university hospitals in Canada, Israel, Austria. Consultant of Kyiv City HIV / AIDS Center. She is a member of pediatric societies ESPID (since1997) and ESID (since 2002). Lecturer on PENTA course in HIV infection since 2013. Priority areas of work: HIV infection, congenital immunodeficiency’s, vaccination.

stevewelchConsultant in Paediatric HIV and Infectious Diseases, Birmingham, UK 2006 onwards; Chair, Children’s HIV Association of the UK and Ireland (CHIVA), 2011-2015; Member of CHIVA Executive Committee and Guidelines Subcommittee, 2008 onwards; Member of British HIV Association (BHIVA) Pregnancy Guideline Committee, 2011; Member of Steering Committee of Paediatric European Network for the Treatment of AIDS (PENTA), 2009 onwards; Lead author of PENTA Guidelines for Treatment of children with HIV infection, 2009; Consultant to WHO treatment guidelines panel for children with HIV infection, 2009. PENTA chair for education 2010 onwards